Innoviva (NASDAQ: INVA) reported Q2 EPS of ($1.14), $1.57 worse than the analyst estimate of $0.43. Revenue for the quarter came in at $119.59 million versus the consensus estimate of $110.94 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.